SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Nutraplus India - Quaterly Results

15 Oct 2024 Evaluate
The revenue for the March 2022 quarter is pegged at Rs. 0.00 millions against Rs. 0.11 millions recorded during the year-ago period.The Net Loss for the quarter ended March 2022 is Rs. -37.04 millions as compared to Net Loss of Rs. -232.25 millions of corresponding quarter ended March 2021 Operating profit Margin for the quarter ended March 2022 improved to -37.04% as compared to -4.17% of corresponding quarter ended March 2021


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202203 202103 % Var 202203 202103 % Var 202203 202103 % Var
Sales 0.00 0.11 0.00 0.98 0.20 390.00 0.98 0.20 390.00
Other Income 0.14 0.57 -75.44 6.20 0.91 581.32 6.20 0.91 581.32
PBIDT -37.04 -4.17 788.25 -30.32 -6.11 396.24 -30.32 -6.11 396.24
Interest 0.00 1.76 -100.00 0.00 4.53 -100.00 0.00 4.53 -100.00
PBDT -37.04 -240.77 -84.62 -30.32 -245.16 -87.63 -30.32 -245.16 -87.63
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT -37.04 -240.77 -84.62 -30.32 -245.16 -87.63 -30.32 -245.16 -87.63
TAX 0.00 -8.52 0.00 0.00 -8.52 0.00 0.00 -8.52 0.00
Deferred Tax 0.00 -8.52 0.00 0.00 -8.52 0.00 0.00 -8.52 0.00
PAT -37.04 -232.25 -84.05 -30.32 -236.64 -87.19 -30.32 -236.64 -87.19
Equity 170.46 170.46 0.00 170.46 170.46 0.00 170.46 170.46 0.00
PBIDTM(%) 0.00 -3790.91 0.00 -3093.88 -3055.00 1.27 -3093.88 -3055.00 1.27

Nutraplus India Share Price

2.10 0.00 (0.00%)
13-Dec-2021 18:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1652.00
Dr. Reddys Lab 1235.20
Cipla 1211.30
Zydus Lifesciences 923.10
Lupin 2312.35
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×